.Nature Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint requires incorporation of clients along with MASLD and dimension of liver end results in cardio-- renal-- metabolic trials, when information recommend mechanistically probable benefits and scientific safety and security-- and outlines considerations for test layout and governing approval.